Clinical Trials Directory

Trials / Unknown

UnknownNCT06073509

Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT

Watch Your HeaRT Study - Screening and Risk Analysis of Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Sophie JACOB · Other Government
Sex
Female
Age
65 Years
Healthy volunteers
Not accepted

Summary

The goal of this interventional study is to evaluate the risk of atrial fibrillation (AF) and other cardiac arrhythmias and diseases in breast cancer patients treated with radiation therapy (RT). In addition to regular follow-up of patients by the radiation oncologist for 5 years, cardiovascular screening at the end of follow-up, combining the use of a connected watch and a cardiological check-up, could make it possible to identify precisely the types and frequencies of these sometimes asymptomatic, and probably underestimated, cardiac diseases. The main questions it aims to answer are: * To assess the incidence of AF and other cardiac arrhythmias and diseases occurring within 5 years after RT * To evaluate absorbed doses in the heart and cardiac substructures (chambers, conduction nodes, coronaries, pulmonary veins) based on auto-segmentation models developped with deep learning algorithms * To investigate whether the risk of AF and other cardiac arrhythmias and diseases is associated with cardiac irradiation characterized by these absorbed doses (dose-response relationship) Participants will be included between 2023 and 2025, 5 years after their RT: * Retrospective data collection will be based on a medical questionnaire designed to identify cardiac pathologies present prior to RT and those having occured in the past, between RT and 5 years post-RT. * Cross-sectional data collection will be based on screening for cardiac pathologies using a connected watch worn for 1 month (silent AF screening) and a cardiology consultation (including ECG and echocardiography) to identify cardiac pathologies at 5 years post-RT possibly not identified in the retrospective data collection.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTScreening for atrial fibrillation and other cardiac arrhythmias and diseasesIn addition to retrospective data collection based on a medical questionnaire, a 5-year post-RT cardiovascular screening will include: * connected smartwatches for atrial fibrillation screening * complete ECG for other cardiac arrhythmias * echocardiography for other cardiac diseases (including cardiac dysfunction, cardiomyopathy, valvulopathy, ...)

Timeline

Start date
2023-10-25
Primary completion
2025-10-20
Completion
2025-11-20
First posted
2023-10-10
Last updated
2023-11-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06073509. Inclusion in this directory is not an endorsement.